Literature DB >> 15300849

Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions.

Catherine Gallou1, Dominique Chauveau, Stéphane Richard, Dominique Joly, Sophie Giraud, Sylviane Olschwang, Natacha Martin, Céline Saquet, Yves Chrétien, Arnaud Méjean, Jean-Michel Correas, Gérard Benoît, Pierre Colombeau, Jean-Pierre Grünfeld, Claudine Junien, Christophe Béroud.   

Abstract

von Hippel-Lindau (VHL) disease arises from mutations in the VHL gene and predisposes patients to develop a variety of tumors in different organs. In the kidney, single or multiple cysts and renal cell carcinomas (RCC) may occur. Both inter- and intrafamilial heterogeneity in clinical expression are well recognized. To identify VHL-dependent genetic factors, we investigated the renal phenotype in 274 individuals from 126 unrelated VHL families in whom 92 different VHL mutations were characterized. The incidence of renal involvement was increased in families with mutations leading to truncated protein (MLTP) or large rearrangement, as compared to families with missense changes (81 vs. 63%, respectively; P=0.03). In the latter group, we identified two mutation cluster regions (MCRs) associated with a high risk of harboring renal lesions: MCR-1 (codons 74-90) and MCR-2 (codons 130-136). In addition, the incidence of RCC was higher in families with MLTP than in families with missense changes (75 vs. 57%; P=0.04). Furthermore, mutations within MCR-1 but not MCR-2 conferred genetic susceptibility to develop RCC. Overall, our data argued for a substantial contribution of the genetic change in the VHL gene to susceptibility to renal phenotype in VHL patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15300849     DOI: 10.1002/humu.20082

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  34 in total

Review 1.  Alterations in VHL as potential biomarkers in renal-cell carcinoma.

Authors:  Lucy Gossage; Tim Eisen
Journal:  Nat Rev Clin Oncol       Date:  2010-04-06       Impact factor: 66.675

Review 2.  Hereditary renal cell carcinoma: genetics, clinical features, and surgical considerations.

Authors:  Timothy K Byler; Gennady Bratslavsky
Journal:  World J Urol       Date:  2014-04-08       Impact factor: 4.226

3.  Clinical and molecular characterization of Brazilian families with von Hippel-Lindau disease: a need for delineating genotype-phenotype correlation.

Authors:  Israel Gomy; Greice Andreotti Molfetta; Ester de Andrade Barreto; Cristiane Ayres Ferreira; Dalila Luciola Zanette; José Cláudio Casali-da-Rocha; Wilson Araujo Silva
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

4.  VHL frameshift mutation as target of nonsense-mediated mRNA decay in Drosophila melanogaster and human HEK293 cell line.

Authors:  Lucia Micale; Lucia Anna Muscarella; Marco Marzulli; Bartolomeo Augello; Patrizia Tritto; Leonardo D'Agruma; Leopoldo Zelante; Gioacchino Palumbo; Giuseppe Merla
Journal:  J Biomed Biotechnol       Date:  2010-01-21

5.  Spinal cord hemangioblastoma : diagnosis and clinical outcome after surgical treatment.

Authors:  Joon Ho Na; Hyeong Soo Kim; Whan Eoh; Jong Hyun Kim; Jong Soo Kim; Eun-Sang Kim
Journal:  J Korean Neurosurg Soc       Date:  2007-12-20

Review 6.  Genetic basis for kidney cancer: opportunity for disease-specific approaches to therapy.

Authors:  Elizabeth Cartwright Pfaffenroth; W Marston Linehan
Journal:  Expert Opin Biol Ther       Date:  2008-06       Impact factor: 4.388

7.  Germline mutations in the von Hippel-Lindau disease (VHL) gene in mainland Chinese families.

Authors:  Jin Zhang; Yiran Huang; Jiahua Pan; Dongming Liu; Lixin Zhou; Wei Xue; Qi Chen; Baijun Dong; Hanqing Xuan
Journal:  J Cancer Res Clin Oncol       Date:  2008-04-30       Impact factor: 4.553

8.  Cancer-causing mutations in a novel transcription-dependent nuclear export motif of VHL abrogate oxygen-dependent degradation of hypoxia-inducible factor.

Authors:  Mireille Khacho; Karim Mekhail; Karine Pilon-Larose; Josianne Payette; Stephen Lee
Journal:  Mol Cell Biol       Date:  2007-10-29       Impact factor: 4.272

9.  Improved detection of germline mutations in Korean VHL patients by multiple ligation-dependent probe amplification analysis.

Authors:  Hyun-Jung Cho; Chang-Seok Ki; Jong-Won Kim
Journal:  J Korean Med Sci       Date:  2009-02-28       Impact factor: 2.153

10.  VHL Type 2B gene mutation moderates HIF dosage in vitro and in vivo.

Authors:  C M Lee; M M Hickey; C A Sanford; C G McGuire; C L Cowey; M C Simon; W K Rathmell
Journal:  Oncogene       Date:  2009-03-02       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.